Neuro-Ophthalmic Consequences of Immune Therapy (PDF)

Update Item Information
Identifier 20200312_nanos_newtreatmentsno1_02-pdf
Title Neuro-Ophthalmic Consequences of Immune Therapy (PDF)
Creator Lynn Gordon, MD, PhD
Subject Cancer; Immunotherapy; Optic Neuropathy; Programmed Death 1 (PD-1); CTLA-4
Description Although immune therapy is used in many types of diseases, from control of systemic inflammatory diseases, to treatment of multiple sclerosis and other demyelinating diseases, to advances in cancer therapy, this presentation concentrates on immune checkpoint inhibition, which is increasing used in cancer immunotherapy.
Date 2020-03
Language eng
Format application/pdf
Source 2020 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2020: New Treatments in Neuro-Ophthalmology-2020 Trends
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2020. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6102czp
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Contributor Primary Lynn Gordon, MD, PhD
Setname ehsl_novel_nam
ID 1543346
Reference URL https://collections.lib.utah.edu/ark:/87278/s6102czp
Back to Search Results